Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00024505 · ClinicalTrials.gov registry record

Multidisciplinary Study of Right Ventricular Dysplasia

A clinical trial of Heart Diseases and Arrhythmogenic Right Ventricular Dysplasia, sponsored by University of Arizona.

Completed
Registry status
320
Enrollment target
1
Study location

NCT00024505: Completed study of Heart Diseases and Arrhythmogenic Right Ventricular Dysplasia, sponsored by University of Arizona.

NCT00024505 is a study of Heart Diseases and Arrhythmogenic Right Ventricular Dysplasia that has completed, run by University of Arizona. The registered enrollment target is 320 participants, below the 5,528-participant average among 85 other Heart Diseases trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00024505, a study of Heart Diseases and Arrhythmogenic Right Ventricular Dysplasia, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
320 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the cardiac, clinical, and genetic aspects of arrhythmogenic right ventricular dysplasia (ARVD), a progressive disorder that predominantly affects the right side of the heart and causes ventricular arrhythmias.

Study Locations (1)

Arizona

  • University of Arizona - Tucson

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2001-09
Est. Completion 2010-07
University of Arizona

349 total trials

What the finished NCT00024505 record still lists

NCT00024505 is an observational study that tracks outcomes without assigning an intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 5,528-participant average among 85 other Heart Diseases trials with a reported enrollment target (94% lower).

The record links to 2 conditions, with Heart Diseases appearing as the primary indexed condition, and to 0 interventions.

NCT00024505 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT00024505 about?

NCT00024505 is a clinical study titled "Multidisciplinary Study of Right Ventricular Dysplasia". The purpose of this study is to investigate the cardiac, clinical, and genetic aspects of arrhythmogenic right ventricular dysplasia (ARVD), a progressive disorder that predominantly affects the right side of the heart and causes ventricular arrhythmias.

What is the current status of trial NCT00024505?

This trial is currently completed. The enrollment target is 320 participants. The study started on 2001-09. Estimated completion is 2010-07.

What conditions does trial NCT00024505 study?

This clinical trial studies the following conditions: Heart Diseases, Arrhythmogenic Right Ventricular Dysplasia.

Who is sponsoring clinical trial NCT00024505?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00024505 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00024505's enrollment target sits among peer trials

320 46th of 85 higher than 40 of 85 other Heart Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02763683 · 320 participants

    Investigations of Dementia in Parkinson Disease

  • NCT03331198 · 320 participants · Phase 1

    Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

  • NCT03458832 · 320 participants

    Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

  • NCT03551951 · 320 participants

    Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00024505, the US trial registry maintained by the National Library of Medicine. NCT00024505 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.